K
Korinna Karampampa
Researcher at Karolinska Institutet
Publications - 26
Citations - 1780
Korinna Karampampa is an academic researcher from Karolinska Institutet. The author has contributed to research in topics: Population & Disability pension. The author has an hindex of 11, co-authored 20 publications receiving 1559 citations.
Papers
More filters
Journal ArticleDOI
Cost of disorders of the brain in Europe 2010
Anders Gustavsson,Mikael Svensson,Frank Jacobi,Christer Allgulander,Jordi Alonso,Ettore Beghi,R. Dodel,Mattias Ekman,Carlo Faravelli,Laura Fratiglioni,Brenda Gannon,David P.H. Jones,Poul Jennum,Albena Jordanova,Linus Jönsson,Korinna Karampampa,Martin Knapp,Martin Knapp,Gisela Kobelt,Tobias Kurth,Roselind Lieb,Mattias Linde,Christina Ljungcrantz,Andreas Maercker,Beatrice Melin,Massimo Moscarelli,Amir Musayev,Fiona Norwood,Martin Preisig,Maura Pugliatti,Juergen Rehm,Luis Salvador-Carulla,Brigitte Schlehofer,Roland Simon,Hans-Christoph Steinhausen,Lars Jacob Stovner,Jean-Michel Vallat,Peter Van den Bergh,Jim van Os,Jim van Os,Pieter E. Vos,Weili Xu,Hans-Ulrich Wittchen,Bengt Jönsson,Jes Olesen +44 more
TL;DR: The present report presents much improved cost estimates for the total cost of disorders of the brain in Europe in 2010, covering 19 major groups of disorders, 7 more than previously, of an increased range of age groups and more cost items.
Journal ArticleDOI
Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from five European countries.
TL;DR: The TRIBUNE study provides an important update on the economic burden of MS in an era of more widespread use of disease-modifying therapies and examines the impact of MS on additional health outcomes beyond utilities such as ADL and fatigue.
Journal Article
Treatment experience, burden, and unmet needs (TRIBUNE) in multiple sclerosis: the costs and utilities of MS patients in Canada.
Korinna Karampampa,Anders Gustavsson,Carolin Miltenburger,Christian M Kindundu,Daniel H Selchen +4 more
TL;DR: Costs of MS patients in Canada are higher today than shown in previous studies, and disease progression and relapses are associated with increased economic and quality of life burden.
Journal ArticleDOI
Declining incidence trends for hip fractures have not been accompanied by improvements in lifetime risk or post-fracture survival – A nationwide study of the Swedish population 60 years and older
Korinna Karampampa,Anders Ahlbom,Karl Michaëlsson,Tomas Andersson,Tomas Andersson,Sven Drefahl,Karin Modig +6 more
TL;DR: The age-specific hip fracture incidence has decreased between 1995 and 2010 in all ages up to 94 years, on average by 1% per year, and the lifetime risk of a hip fracture has not decreased because life expectancy in the population has increased in parallel.
Journal ArticleDOI
Treatment experience, burden, and unmet needs (TRIBUNE) in Multiple Sclerosis study: the costs and utilities of MS patients in The Netherlands
Korinna Karampampa,Anders Gustavsson,Erik van Munster,Raymond Hupperts,Evert Sanders,Jop Mostert,Okke L G F Sinnige,Jaap de Graaf,P. H. M. Pop,Carolin Miltenburger,Martijn Groot,Milon Relleke,W. S. van der Hel +12 more
TL;DR: The TRIBUNE study provides an important update on the economic burden of MS in The Netherlands in an era of more widespread use of disease-modifying therapies and examines the impact of MS on additional health outcomes beyond utilities such as ADL and fatigue.